Flaviviruses in AntiTumor Therapy
Viruses · 2023
DOI: 10.3390/v15101973 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Viruses, 2023. Verfasst von Alina S Nazarenko und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Tick-Borne Encephalitis and Other Viral Encephalitides, Chumakov Federal Scientific Center for Research and Development of Immune-and-B…. Hauptthemen laut MEDLINE: Flavivirus, Oncolytic Virotherapy, Oncolytic Viruses, Brain Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Federation.
Abstract (Originalsprache)
Oncolytic viruses offer a promising approach to tumor treatment. These viruses not only have a direct lytic effect on tumor cells but can also modify the tumor microenvironment and activate antitumor immunity. Due to their high pathogenicity, flaviviruses have often been overlooked as potential antitumor agents. However, with recent advancements in genetic engineering techniques, an extensive history with vaccine strains, and the development of new attenuated vaccine strains, there has been a renewed interest in the Flavivirus genus. Flaviviruses can be genetically modified to express transgenes at acceptable levels, and the stability of such constructs has been greatly improving over the years. The key advantages of flaviviruses include their reproduction cycle occurring entirely within the cytoplasm (avoiding genome integration) and their ability to cross the blood–brain barrier, facilitating the systemic delivery of oncolytics against brain tumors. So far, the direct lytic effects and immunomodulatory activities of many flaviviruses have been widely studied in experimental animal models across various types of tumors. In this review, we delve into the findings of these studies and contemplate the promising potential of flaviviruses in oncolytic therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Tick-Borne Encephalitis and Other Viral Encephalitides, Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Moscow 108819, Russ…
- Institute of Translational Medicine and Biotechnology, Sechenov First Moscow State Medical University, Moscow 119991, Russia.
Förderung
- Russian Federation
Zitieren
APA
Nazarenko, A. S., Vorovitch, M. F., Biryukova, Y. K., Pestov, N. B., Orlova, E. A., Barlev, N. A., Kolyasnikova, N. M., & Ishmukhametov, A. A. (2023). Flaviviruses in AntiTumor Therapy. Viruses. https://doi.org/10.3390/v15101973
Vancouver
Nazarenko AS, Vorovitch MF, Biryukova YK, Pestov NB, Orlova EA, Barlev NA, et al. Flaviviruses in AntiTumor Therapy. Viruses. 2023. doi:10.3390/v15101973
BibTeX
@article{Nazarenko2023,
author = {Nazarenko, Alina S and Vorovitch, Mikhail F and Biryukova, Yulia K and Pestov, Nikolay B and Orlova, Ekaterina A and Barlev, Nickolai A and Kolyasnikova, Nadezhda M and Ishmukhametov, Aydar A},
title = {Flaviviruses in AntiTumor Therapy},
journal = {Viruses},
year = {2023},
doi = {10.3390/v15101973}
}
EUVIMED